Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

21st Century Entrepreneurship

Chris Mirabile: Unpacking the Secret to Slow Aging and Enhance Longevity

19 Jul 2023

Description

In this engaging episode, Chris Mirabile, the founder and CEO of Novos Labs, shares his inspiring journey through the intricate world of anti-aging and longevity. As the visionary behind the first human longevity company addressing the 12 Mechanisms of Aging, Chris pulls back the curtain on his innovative, patent-pending formulations designed to enhance life's longevity.From personal lifestyle decisions to the science of aging, he discusses a myriad of factors that influence our aging process, revealing the surprising truth about the role genetics play. With a strategic focus on the importance of lifestyle choices, he explores critical areas such as nutrition, physical activity, psychology, relationships, and our physical environments.By dissecting the modern lifestyle's complexities, Chris provides valuable insights into maintaining our health and longevity in a challenging world. From the power of intermittent fasting and balanced exercise to the role of intelligent supplementation, he gives listeners actionable steps to take control of their health today.With a treasure trove of scientific references and practical advice, this episode empowers listeners to pursue a longer, healthier life. Chris also invites listeners to explore the wealth of resources available at Novos Labs, including a longevity quiz, a facial age AI tool, and a comprehensive blog populated with expert articles.Dive into this episode to discover how you can actively influence your health and longevity with Chris Mirabile, the pioneering force behind Novos Labs.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.